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ahoo.fr (Abstract Solitary ﬁbrous tumour (SFT) is an uncommon spindle-cell neoplasm of mesenchymal
origin occurring in the face.
We report a clinical case of SFT of the cheek. This entity is rarely observed on this site.
The clinical behaviour is widely different and the diagnosis depends on the immunohistochemical
results. In our report, we clarify these features. The treatment consists of complete surgical removal,
better performed when previously associated with embolisation.
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I.M. Turki).1. Introduction
Solitary ﬁbrous tumour (SFT) is an uncommon spindle-cell
neoplasm of mesenchymal origin. It frequently appears in
the pleura that was the ﬁrst report in 1931.1
SFT arises from the ubiquitous interstitial stem cells in var-
ious soft tissues of the whole body, including the head. The
cheek is rarely reported in the literature.2
The clinical behaviour is widely different and the diagnosis
depends on the immunohistochemical examination.3 In our re-
port, we clarify these features and emphasize on the great ben-
eﬁt of the embolisation when realized before surgery.
2. Case report
A 28-year-old woman presented with a swelling in the right
cheek growing gradually over 4 months after her delivery.
There was no history of trauma. On clinical examination, there
Figure 2 The supply by the facial artery, angiogram showing
tumour blush.
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right cheek. This lump was 4 centimetre (cm) in diameter, ﬁrm
and relatively ﬁxed on the deep plane. Both overlying skin and
mucosa were intact. There was no trouble on the sensory and
motor function of the face. Our patient had not any lymph
node.
Radiologically, the patient was investigated with magnetic
resonance imaging (MRI) with gadolinium contrast. The
lesion was reported as a hypervascular solid mass within the
fat of the right cheek (Fig 1).
In order to exclude bone involvement a computerised
tomography (CT) study was performed. The CT did not indi-
cate any bony destruction of the maxilla.
We suspected either a benign hypervascular tumour or a
vascular malformation. That is why we decided to perform
an embolisation before surgery to avoid an important bleeding.
Angiography indicated that the lesion is hypervascular and
received arterial supply from muscular branches of the internal
maxillary artery (IMA) and from the angular branch of the fa-
cial artery (Fig 2). Embolisation of these branches was
achieved with absorbable gelatine sponge. Post embolisation
angiogram showed complete devascularisation of the lesion
(Fig. 3).
This woman was operated under general anaesthesia, one
day after embolisation, with a vestibular incision discovering
the tumour. It was not encapsulated but well circumscribed
(Fig. 4). There was no lesion on the maxillary nerve (V2)
and no erosion on the adjacent bone. The tumour was com-
pletely removed with no haemorrhagic accident.
The histological appearance of the specimen was that of a
cellular ﬁbrous tissue, within the spindle shaped ﬁbroblastic
cells were arranged in a rather ‘‘patternless’’ way. Immunohis-
tochemical staining for markers CD34, CD99 and Bcl-2 was
positive, whereas staining for S100 and neuroﬁlament was neg-
ative. So SFT was conﬁrmed.Figure 1 Post contrast T1 MRI coronal view showing a high
vascular mass of the right cheek.
Figure 3 Post embolisation angiogram showing complete
devascularisation of the lesion.
Figure 4 Intra-operative view of the mass and excised specimen.Clinical examination and Post contrast MRI was per-
formed one year after surgical resection and did not show
any recurrence of the lesion.
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Solitary ﬁbrous tumour (SFT) is a rare benign soft-tissue neo-
plasm usually encountered in the pleura and was believed to
arise from submesothelial primitive mesenchymal cells. Several
extrapleural sites are described such as the respiratory tract,
lung, breast, meninges and the cervicofacial region, even
observed in the sinusal tract, the thyroı¨d, the salivary glands,
the tongue, the scalp and the cheek. Since then studies empha-
size that SFT is distinct from pleural mesothelioma and the
origin of SFT is the ubiquitous interstitial stem cells in various
soft tissues.2,4,5
In the oral region, SFT accounts for 3% of all the cases
documented in the literature. Both men and women can be
affected at the same range and mainly middle aged and elderly
patients.6
Symptoms depend on the site and the deepness of the
tumour. Usually, slow growing and asymptomatic mass is
described with an overlying normal skin and mucosa. There
is no erosion of the adjacent bone as seen in our case. How-
ever, aggressive or malignant SFTs grow rapidly and can have
a regional extension, even metastasis can occur to the lung, the
liver and the bone.4,7
Sometimes, few patients with SFT show a hypoglycaemia
explained by the possibility of this tumour to secrete an ‘‘insu-
lin like factor’’.8
Most cytogenetic studies report numerical abnormalities of
chromosomes involving gain of chromosome 21, rearrange-
ment of 9q22 and loss of chromosomes 3, 4, 9, 13 and 22.
These chromosomal changes may have a role of tumouri-
genesis of SFT but no genes were suggested or identiﬁed.2,9
Radiologically, whether by magnetic resonance imaging
MRI, computerized tomography CT or plain X-ray ﬁlm SFT
is not speciﬁc and appears as a richly vascularised soft tissue
mass which is better identiﬁed with an angiography.7 Because
of the well known hypervascularity of this tumour, embolisa-
tion of the blood vessels supplying the tumour is helpful before
the surgical approach. We believe that surgery combined with
radiological embolisation is the treatment of choice. We did
not ﬁnd this reported in the literature.
The histological diagnosis remains difﬁcult because the
wide morphologic spectrum exhibited by SFT generates a dif-
ferential diagnosis essentially with hemangiopericytoma, leio-
myosarcoma and desmoplastic ﬁbroma.
The diagnosis of SFT is always and necessarily conﬁrmed
by an immunohistochemical analysis that shows the positivity
for the immunoreactive CD34, CD99 and Bcl-2 of the tumour
cells.
Both leiomyosarcoma and desmoplastic ﬁbroma have no
expression for CD34. However, we never ﬁnd a positiveexpression for CD 99 in hemangiopericytoma (HPC). At pres-
ent, many authors believe that HPC and SFT represent the
same pathologic entity.3,6,7
It’s also important to search some histological features pre-
dicting malignancies such as the lack of circumscription, nucle-
ar atypia, hypercellularity and the presence of necrosis. These
features conclude to an aggressive or malignant SFT and even
if the surgical treatment is complete it must sometimes be car-
ried with radiotherapy and chemotherapy.10
All the authors required a long term follow up, both clinical
and radiological examination, to detect recurrence or its possi-
ble malignant transformation.4,7
In conclusion, SFT is extremely rare in the cheek. Its diag-
nosis depends on immunohistological examination.
The treatment of choice is the complete surgical excision bet-
ter performed when previously associated with embolisation.
A long term follow up is necessary to detect recurrence or a
possible malignant transformation.
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